Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Maternal vitamin D status and child morbidity, anemia, and growth in human immunodeficiency virus-exposed children in Tanzania.
Finkelstein JL, Mehta S, Duggan C, Manji KP, Mugusi FM, Aboud S, Spiegelman D, Msamanga GI, Fawzi WW.
Pediatr Infect Dis J. 2012 Feb;31(2):171-5.
Related citations
The Effect of Early Initiation of Antiretroviral Treatment in Infants Receiving Pediatric Auto Immune Deficiency Syndrome Mortality in South Africa: A Model-Based Analysis.
Johnson LF, Davies MA, Moultrie H, Sherman GG, Bland RM, Rehle TM, Dorrington RE, Newell ML.
Pediatr Infect Dis J. 2011 Dec 23. [Epub ahead of print]
The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis.
Pediatr Infect Dis J. 2012 May;31(5):474-80.
Immunologic response to oral polio vaccine in human immunodeficiency virus-infected and uninfected Zimbabwean children.
Gnanashanmugam D, Troy SB, Musingwini G, Huang C, Halpern MS, Stranix-Chibanda L, Shetty AK, Kouiavskaia D, Nathoo K, Chumakov K, Maldonado YA.
Pediatr Infect Dis J. 2012 Feb;31(2):176-80.
Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation.
Prasitsuebsai W, Cressey TR, Capparelli E, Vanprapar N, Lapphra K, Chokephaibulkit K.
Pediatr Infect Dis J. 2012 Apr;31(4):389-91.
Recovery from lipodystrophy in HIV-infected children after substitution of stavudine with zidovudine in a non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Aurpibul L, Puthanakit T, Taejaroenkul S, Sirisanthana T, Sirisanthana V.
Pediatr Infect Dis J. 2012 Apr;31(4):384-8.
Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.
Crain MJ, Williams PL, Griner R, Tassiopoulos K, Read JS, Mofenson LM, Rich KC; Pediatric HIVAIDS Cohort Study.
Pediatr Infect Dis J. 2011 Dec;30(12):1069-74.
Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006.
Setse RW, Siberry GK, Gravitt PE, Moss WJ, Agwu AL, Wheeling JT, Bohannon BA, Dominguez KL; LEGACY Consortium.
Pediatr Infect Dis J. 2011 Nov;30(11):967-73.
The performance of 5 rapid HIV tests using whole blood in infants and children: selecting a test to achieve the clinical objective.
Sherman GG, Lilian RR, Coovadia AH.
Pediatr Infect Dis J. 2012 Mar;31(3):267-72.
Reduction in mycobacterial disease among HIV-infected children in the highly active antiretroviral therapy era (1997-2008).
Jensen J, Álvaro-Meca A, Micheloud D, Díaz A, Resino S.
Pediatr Infect Dis J. 2012 Mar;31(3):278-83.
Staphylococcus aureus infections in HIV-positive children and adolescents.
McNeil JC, Hulten KG, Kaplan SL, Schwarzwald HL, Mason EO.
Pediatr Infect Dis J. 2012 Mar;31(3):284-6.
Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors.
Thampi N, Stephens D, Rea E, Kitai I.
Pediatr Infect Dis J. 2012 Feb;31(2):129-33.
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children.
Siberry GK, Warshaw MG, Williams PL, Spector SA, Decker MD, Jean-Philippe P, Yogev R, Heckman BE, Manzella A, Roa J, Nachman S, Lujan-Zilbermann J; IMPAACT P1065 Protocol Team.
Pediatr Infect Dis J. 2012 Jan;31(1):47-52.
Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection.
Sturt AS, Halpern MS, Sullivan B, Maldonado YA.
Pediatr Infect Dis J. 2012 Jan;31(1):53-60.
Simplified human immunodeficiency virus maintenance therapy in virologically suppressed children with Ritonavir-boosted protease inhibitor monotherapy.
Neth O, Falcon-Neyra L, Ruiz-Valderas R, León Leal JA, Obando I, Alvarez Del Vayo Benito C, Lopez-Cortes LF.
Pediatr Infect Dis J. 2011 Oct;30(10):917. No abstract available.
Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children.
Punpanich W, Groome M, Muhe L, Qazi SA, Madhi SA.
Pediatr Infect Dis J. 2011 Oct;30(10):e192-202. Review.
Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon.
Fokam J, Salpini R, Santoro MM, Cento V, Perno CF, Colizzi V, Ndumbe PM, Fokunang Ntungen C, Ndiang Tetang SM, Nanfack AJ, Takou Komego DA, Cappelli G.
Pediatr Infect Dis J. 2011 Dec;30(12):1062-8.
Severe myelosuppression and MRSA infection as the presentation of perinatal HIV infection.
Rhee EJ, Linden C, Adler A, Burns J, Marcinak J.
Pediatr Infect Dis J. 2011 Aug;30(8):727-8. No abstract available.
Increased risk of death in human immunodeficiency virus-infected children with pneumococcal meningitis in South Africa, 2003-2005.
Nyasulu P, Cohen C, De Gouveia L, Feldman C, Klugman KP, von Gottberg A; Group for Enteric, Respiratory and Meningeal Diseases Surveillance in South Africa (GERMS-SA).
Pediatr Infect Dis J. 2011 Dec;30(12):1075-80.
Antiretroviral therapy responses among children attending a large public clinic in Soweto, South Africa.
Meyers TM, Yotebieng M, Kuhn L, Moultrie H.
Pediatr Infect Dis J. 2011 Nov;30(11):974-9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on